Published in Med Sci Monit on April 01, 2012
Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients. J Thorac Dis (2013) 0.83
Mesenchymal stem cells suppress CaN/NFAT expression in the pulmonary arteries of rats with pulmonary hypertension. Exp Ther Med (2015) 0.78
Upregulation of Transient Receptor Potential Canonical Channels Contributes to Endotoxin-Induced Pulmonary Arterial Stenosis. Med Sci Monit (2016) 0.75
The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism. Med Sci Monit (2013) 0.75
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
Bosentan therapy for pulmonary arterial hypertension. N Engl J Med (2002) 11.18
Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (2005) 9.27
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med (1996) 8.02
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet (1981) 6.48
Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet (2008) 5.01
Primary pulmonary hypertension. N Engl J Med (1997) 4.97
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med (1980) 4.81
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol (2002) 4.79
Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation (2002) 4.42
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med (2002) 3.91
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med (2008) 3.13
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation (2006) 3.05
Tadalafil therapy for pulmonary arterial hypertension. Circulation (2009) 2.98
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation (2005) 2.98
Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol (1998) 2.90
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation (2006) 2.67
Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest (2007) 2.67
Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64
Chronic thromboembolic pulmonary hypertension. Circulation (2006) 2.58
Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.57
Primary pulmonary hypertension. Lancet (1998) 2.47
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J (2006) 2.39
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med (2000) 2.18
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.00
Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med (2005) 1.91
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med (2006) 1.86
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2006) 1.84
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. J Heart Lung Transplant (2006) 1.78
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial. Chest (2006) 1.64
Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med (1999) 1.63
Chronic cor pulmonale. Etiology and management. JAMA (1990) 1.63
Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.56
Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax (2003) 1.56
Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation (1999) 1.47
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol (2004) 1.42
Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med (1996) 1.42
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med (2005) 1.35
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol (1998) 1.29
Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol (1985) (1995) 1.22
The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest (1998) 1.15
Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 1.13
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Eur Heart J (2005) 1.13
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med (1999) 1.13
Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006. MMWR Morb Mortal Wkly Rep (2007) 1.12
Definition, classification, and epidemiology of pulmonary arterial hypertension. Semin Respir Crit Care Med (2009) 1.12
Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl (2008) 1.09
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol (1999) 1.09
Prostanoids for pulmonary arterial hypertension. Am J Respir Med (2003) 1.08
Diagnosis and treatment of pulmonary hypertension. Am Fam Physician (2001) 1.01
Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med (2011) 1.01
Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan. Chest (2008) 0.91
Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience. J Thorac Cardiovasc Surg (2005) 0.88
Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension. Am J Cardiol (2011) 0.85
Hypoxia during air travel in adults with pulmonary disease. Am J Med Sci (2008) 0.84
Risk factors for reperfusion injury after lung transplantation. Intensive Care Med (2006) 0.83
Predictors of cardiac hepatopathy in patients with right heart failure. Med Sci Monit (2011) 0.81
Surgical and interventional therapies for pulmonary arterial hypertension. Semin Respir Crit Care Med (2005) 0.77
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation (2006) 3.40
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Cardiac sarcoidosis: a comprehensive review. Arch Med Sci (2011) 1.61
Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. J Invasive Cardiol (2010) 1.57
Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol (2006) 1.56
Hyponatremia and cerebrovascular spasm in aneurysmal subarachnoid hemorrhage. Neurol India (2006) 1.54
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail (2010) 1.50
Predictors of mortality, rehospitalization for syncope, and cardiac syncope in 352 consecutive elderly patients with syncope. J Am Med Dir Assoc (2013) 1.49
Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens (2015) 1.45
Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. J Am Med Dir Assoc (2008) 1.43
Patients with infective endocarditis and increased cardiac troponin I levels have a higher incidence of in-hospital mortality and valve replacement than those with normal cardiac troponin I levels. Cardiology (2008) 1.41
Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home. J Am Med Dir Assoc (2007) 1.40
Hormone replacement therapy. An analysis of efficacy based on evidence. Geriatrics (2002) 1.40
Treatment of postmenopausal osteoporosis. Compr Ther (2007) 1.40
Drug therapy of older persons with hypertension. J Am Med Dir Assoc (2006) 1.38
A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J (2009) 1.34
Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J (2006) 1.32
Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther (2007) 1.32
Intravascular device infections: epidemiology, diagnosis, and management. Cardiol Rev (2006) 1.30
A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure. Am J Cardiol (2009) 1.24
Association of interatrial block with development of atrial fibrillation. Am J Cardiol (2003) 1.22
Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol (2011) 1.19
Blood pressure j-curve: current concepts. Curr Hypertens Rep (2012) 1.18
A propensity-matched study of outcomes of chronic heart failure (HF) in younger and older adults. Arch Gerontol Geriatr (2008) 1.18
The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe. Curr Cardiovasc Risk Rep (2011) 1.17
ST-elevation myocardial infarction in the elderly--temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States. Int J Cardiol (2013) 1.16
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol (2015) 1.15
Quality of care of nursing home residents hospitalized with heart failure. J Am Geriatr Soc (2002) 1.14
Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol (2005) 1.14
Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol (2010) 1.13
Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology practice. Arch Med Sci (2012) 1.12
Therapeutic options for severe asthma. Arch Med Sci (2012) 1.11
Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). Am J Cardiol (2010) 1.08
Risk factor reduction in progression of angiographic coronary artery disease. Arch Med Sci (2012) 1.08
Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema. Am J Ther (2007) 1.07
Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Arch Med Sci (2010) 1.07
Not All NSTEMIs Are Created Equal. J Am Coll Cardiol (2015) 1.07
Prevalence of coronary artery disease, lower extremity peripheral arterial disease, and cerebrovascular disease in 110 men with an abdominal aortic aneurysm. Am J Cardiol (2004) 1.07
Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc (2014) 1.06
Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy. Curr Pharm Des (2012) 1.06
Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology (2014) 1.05
Lipid, blood pressure and kidney update 2013. Int Urol Nephrol (2014) 1.05
Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol (2005) 1.04
Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study. J Am Soc Hypertens (2010) 1.04
Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia. Am J Cardiol (2006) 1.04
Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents. J Am Med Dir Assoc (2003) 1.04
Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease. Cardiology (2005) 1.03
Statin therapy in the elderly: a review. Arch Gerontol Geriatr (2009) 1.03
Carcinoid heart disease. Cardiol Rev (2012) 1.03
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med (2013) 1.03
The effects of off-normal hours, age, and gender for coronary angioplasty on hospital mortality in patients undergoing coronary angioplasty for acute myocardial infarction. Am J Cardiol (2004) 1.02
Prediction of moderate or severe pulmonary hypertension by main pulmonary artery diameter and main pulmonary artery diameter/ascending aorta diameter in pulmonary embolism. Cardiol Rev (2006) 1.01
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol (2009) 1.01
Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease. Cardiol Rev (2007) 1.00
Diagnosis of heart failure in older adults: predictive value of dyspnea at rest. Arch Gerontol Geriatr (2004) 1.00
Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus. Am J Cardiol (2006) 1.00
Demographics and payment characteristics of nursing home residents in the United States: a 23-year trend. J Gerontol A Biol Sci Med Sci (2004) 1.00
Cardiac amyloidosis: approaches to diagnosis and management. Cardiol Rev (2009) 0.99
The meaning of hypokalemia in heart failure. Int J Cardiol (2011) 0.98
Double contrast-enhanced ultrasonography evaluation of preoperative Lauren classification of advanced gastric carcinoma. Arch Med Sci (2011) 0.98
Isolated diastolic hypotension and incident heart failure in older adults. Hypertension (2011) 0.96
Thoracic aortic atheroma severity predicts high-risk coronary anatomy in patients undergoing transesophageal echocardiography. Arch Med Sci (2011) 0.96
Association of warfarin use with valvular and vascular calcification: a review. Clin Cardiol (2011) 0.95
Mortality at long-term follow-up of patients with no, nonobstructive, and revascularized 1-, 2-, and 3-vessel obstructive coronary artery disease. Med Sci Monit (2010) 0.95
Current place of beta-blockers in the treatment of hypertension. Curr Vasc Pharmacol (2010) 0.94
Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults. Ann Med (2012) 0.93
Systolic compression of left main coronary artery by left ventricular pseudoaneurysm complicated by critical stenosis of left main coronary artery. Arch Med Sci (2012) 0.93
Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial. J Gerontol A Biol Sci Med Sci (2005) 0.93
Effect of serum insulin on the association between hyperuricemia and incident heart failure. Am J Cardiol (2010) 0.92
Evaluation of left ventricular dyssynchrony using combined pulsed wave and tissue Doppler imaging. Arch Med Sci (2010) 0.92
Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. Am J Cardiol (2010) 0.92
Differences of lateral and septal mitral annulus velocity by tissue Doppler imaging in the evaluation of left ventricular diastolic function. Am J Cardiol (2006) 0.92
Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn (2011) 0.91
Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol A Biol Sci Med Sci (2005) 0.91
Etiology of syncope in patients hospitalized with syncope and predictors of mortality and rehospitalization for syncope at 27-month follow-up. Clin Cardiol (2011) 0.91
Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. Am J Cardiol (2004) 0.91
Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction. Am J Cardiol (2013) 0.90
Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study. Circ Heart Fail (2009) 0.90
Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol (2006) 0.90
Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol (2008) 0.90
Menopausal symptoms after cessation of hormone replacement therapy. Maturitas (2005) 0.90
Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol (2010) 0.89
Anomalous origin of the left main coronary artery from the right sinus of Valsalva with an intramural course identified by transesophageal echocardiography in a 14 year old with acute myocardial infarction. Cardiol Rev (2005) 0.89
Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia. Am J Ther (2007) 0.89
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin Drug Saf (2015) 0.89
Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renovasc Dis (2009) 0.89
Thromboembolism in patients with atrial fibrillation with and without left atrial thrombus documented by transesophageal echocardiography. Am J Ther (2009) 0.88
Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience. Clin Cardiol (2010) 0.88
Nephroprotective and clinical potential of statins in dialyzed patients. Expert Opin Ther Targets (2009) 0.88
Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: a follow-up study. Am J Ther (2006) 0.88